262 related articles for article (PubMed ID: 36792077)
21. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
[TBL] [Abstract][Full Text] [Related]
22. Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.
Zhao Y; Wang R; Shen X; Pan Y; Cheng C; Li Y; Shen L; Zhang Y; Li H; Zheng D; Ye T; Zheng S; Sun Y; Chen H
Ann Surg Oncol; 2016 Jun; 23(6):2099-105. PubMed ID: 26842488
[TBL] [Abstract][Full Text] [Related]
23. Predictive accuracy of lepidic growth subtypes in early-stage adenocarcinoma of the lung by quantitative CT histogram and FDG-PET.
Eriguchi D; Shimada Y; Imai K; Furumoto H; Okano T; Masuno R; Matsubayashi J; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2018 Nov; 125():14-21. PubMed ID: 30429012
[TBL] [Abstract][Full Text] [Related]
24. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
25. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
[TBL] [Abstract][Full Text] [Related]
26. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
Kim M; Chung YS; Kim KA; Shim HS
Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
[TBL] [Abstract][Full Text] [Related]
28. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
30. Validation of the novel International Association for the Study of Lung Cancer grading system and prognostic value of filigree micropapillary and discohesive growth pattern in invasive pulmonary adenocarcinoma.
Zhang Y; Zhang Y; Hu Y; Zhang S; Zhu M; Hu B; Guo X; Lu J; Zhang Y
Lung Cancer; 2023 Jan; 175():79-87. PubMed ID: 36481678
[TBL] [Abstract][Full Text] [Related]
31. Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.
Sakurai H; Asamura H; Miyaoka E; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Okumura M; Yokoi K;
Eur J Cardiothorac Surg; 2014 Jan; 45(1):100-7. PubMed ID: 23729748
[TBL] [Abstract][Full Text] [Related]
32. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of histopathology in invasive lung adenocarcinoma: a comparative review of the main proposed grading systems.
Lucà S; Zannini G; Morgillo F; Della Corte CM; Fiorelli A; Zito Marino F; Campione S; Vicidomini G; Guggino G; Ronchi A; Accardo M; Franco R
Expert Rev Anticancer Ther; 2023 Mar; 23(3):265-277. PubMed ID: 36772823
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
35. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.
Yoshizawa A; Motoi N; Riely GJ; Sima CS; Gerald WL; Kris MG; Park BJ; Rusch VW; Travis WD
Mod Pathol; 2011 May; 24(5):653-64. PubMed ID: 21252858
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of stage I lung adenocarcinoma: A retrospective study based on analysis of 110 Chinese patients.
Zhao X; Zhang Y; Qian K; Zhao L; Wang W; Teng LH
Thorac Cancer; 2017 Nov; 8(6):565-571. PubMed ID: 28834269
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact according to the proportion of the lepidic subtype in stage IA acinar-predominant lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(14):2072-2077. PubMed ID: 34033216
[TBL] [Abstract][Full Text] [Related]
39. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma.
Yotsukura M; Asamura H; Suzuki S; Asakura K; Yoshida Y; Nakagawa K; Sakurai H; Watanabe SI; Motoi N
Lung Cancer; 2020 Jul; 145():158-166. PubMed ID: 32450494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
